Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
8.61
-0.07 (-0.81%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Champions Oncology Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jan '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2019 - 2015
Revenue
58.5950.1653.8749.1141.0432.12
Upgrade
Revenue Growth (YoY)
19.03%-6.90%9.70%19.66%27.76%18.68%
Upgrade
Cost of Revenue
28.3729.429.5323.6321.4517
Upgrade
Gross Profit
30.2220.7524.3425.4819.5915.12
Upgrade
Selling, General & Admin
16.5918.1317.2415.512.0310.86
Upgrade
Research & Development
6.919.5411.559.377.25.85
Upgrade
Operating Expenses
23.527.6828.7924.8719.2316.71
Upgrade
Operating Income
6.72-6.92-4.450.610.37-1.59
Upgrade
Interest Expense
-0.03-0.03----
Upgrade
Interest & Investment Income
0.090.09----
Upgrade
Currency Exchange Gain (Loss)
-0.02-0.02-0.01-0.02-0.01-
Upgrade
Other Non Operating Income (Expenses)
0.06-----0.09
Upgrade
EBT Excluding Unusual Items
6.84-6.87-4.460.580.36-1.68
Upgrade
Impairment of Goodwill
------0.34
Upgrade
Gain (Loss) on Sale of Assets
-0.44-0.44---0.05
Upgrade
Asset Writedown
---0.81---
Upgrade
Other Unusual Items
----0.08-
Upgrade
Pretax Income
6.4-7.31-5.270.580.44-1.96
Upgrade
Income Tax Expense
-0.03-0.030.070.040.080.13
Upgrade
Net Income
6.43-7.28-5.340.550.36-2.09
Upgrade
Net Income to Common
6.43-7.28-5.340.550.36-2.09
Upgrade
Net Income Growth
---51.38%--
Upgrade
Shares Outstanding (Basic)
141414131312
Upgrade
Shares Outstanding (Diluted)
141414141512
Upgrade
Shares Change (YoY)
3.30%0.04%-4.37%-2.84%23.05%-15.98%
Upgrade
EPS (Basic)
0.47-0.54-0.390.040.03-0.18
Upgrade
EPS (Diluted)
0.46-0.54-0.390.040.02-0.18
Upgrade
EPS Growth
---100.01%--
Upgrade
Free Cash Flow
-1.43-6.971.14.11-4.960.69
Upgrade
Free Cash Flow Per Share
-0.10-0.520.080.29-0.340.06
Upgrade
Gross Margin
51.58%41.38%45.18%51.88%47.74%47.08%
Upgrade
Operating Margin
11.48%-13.80%-8.26%1.24%0.89%-4.94%
Upgrade
Profit Margin
10.97%-14.51%-9.90%1.12%0.88%-6.52%
Upgrade
Free Cash Flow Margin
-2.44%-13.90%2.04%8.38%-12.09%2.13%
Upgrade
EBITDA
8.43-5.05-2.832.231.55-0.76
Upgrade
EBITDA Margin
14.38%-10.08%-5.26%4.55%3.78%-2.37%
Upgrade
D&A For EBITDA
1.71.871.621.631.180.83
Upgrade
EBIT
6.72-6.92-4.450.610.37-1.59
Upgrade
EBIT Margin
11.48%-13.80%-8.26%1.24%0.89%-4.94%
Upgrade
Effective Tax Rate
---6.00%17.16%-
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q